ArticleJournal of oncology2021

Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma.

Zhitao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.